The US Food and Drug Administration (FDA) has authorised a third dose of COVID-19 vaccines by Pfizer and Moderna for people with compromised immune systems who are likely to have weaker protection from the two-dose regimens. 
Key points:

• Transplant recipients…

Click here to view the original article.